Does LINACLOTIDE Cause Product packaging quantity issue? 131 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Product packaging quantity issue have been filed in association with LINACLOTIDE (Linzess). This represents 1.0% of all adverse event reports for LINACLOTIDE.
131
Reports of Product packaging quantity issue with LINACLOTIDE
1.0%
of all LINACLOTIDE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product packaging quantity issue From LINACLOTIDE?
Of the 131 reports, 1 (0.8%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LINACLOTIDE. However, 131 reports have been filed with the FAERS database.
What Other Side Effects Does LINACLOTIDE Cause?
Diarrhoea (3,638)
Drug ineffective (3,560)
Off label use (2,634)
Constipation (1,123)
Abdominal distension (861)
Abdominal pain (674)
Abdominal pain upper (571)
Flatulence (554)
Inappropriate schedule of product administration (547)
Intentional product misuse (462)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which LINACLOTIDE Alternatives Have Lower Product packaging quantity issue Risk?
LINACLOTIDE vs LINAGLIPTIN
LINACLOTIDE vs LINAGLIPTIN\METFORMIN
LINACLOTIDE vs LINCOMYCIN
LINACLOTIDE vs LINEZOLID
LINACLOTIDE vs LINZESS